Leidos Holdings, US5253271028

Leidos Holdings stock gained 1.45 percent as JV closes

Published on 10/07/2026 at 03:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Leidos Holdings stock now reflects a joint venture in which the company retained 41.5 percent. Q2 revenue reached USD 4.56 billion, up 7.2 percent year over year.

Isometrische 3D-Grafik der Prozesskette von Satellitendaten bis zur Missionssteuerung
Isometrische 3D-Grafik illustriert fuer Leidos Holdings ISIN US5253271028 die Kette von Satellitendaten bis Missionssteuerung, Illustration mit AI erstellt.

Leidos Holdings stock was last at USD 119.45 on the NYSE on October 5, 2026, up 1.45 percent for the session. The company had just completed a security screening joint venture with a 41.5 percent retained stake, giving investors a fresh strategic marker for the business.

Joint venture changes the mix

According to StockTitan on October 5, 2026, Leidos contributed its Security Enterprise Solutions and Industrial Automation businesses to Nickel JV Ultimate Parent in exchange for 41.5 percent of the equity. The Altaris entities received 58.5 percent, while Leidos retained minority investor protections and liquidity rights after the seven-year anniversary.

The transaction places security imaging, detection and automation assets under the Analogic brand. For Leidos, the immediate investor question is how the portfolio change supports its NorthStar 2030 strategy while concentrating the remaining company on defense, intelligence, civil infrastructure and health services.

Q2 figures set the baseline

Leidos reported on August 4, 2026, that Q2 2026 revenue reached USD 4.6 billion, up 7 percent year over year. Net income was USD 356 million, diluted EPS was USD 2.81, adjusted EBITDA was USD 631 million and adjusted EBITDA margin was 13.8 percent.

The earnings mix was uneven. Fortune reported that management raised the midpoint of 2026 revenue guidance by USD 100 million and highlighted a 2.2 book-to-bill ratio in Defense, while Health faced suspended incentive payments in the Veterans Affairs medical examination business.

That contrast matters because the defense pipeline is expanding while the health segment carries a clearer execution risk. Management also cited USD 5 billion in Q2 net awards and nearly USD 800 million in quarterly operating cash flow, supporting the argument that contract flow remains the main earnings variable.

Targets sit above the stock

According to MarketBeat, 17 analysts give Leidos a Hold consensus and an average price target of USD 160.29. That target lies 34.2 percent above the October 5 price of USD 119.45, a quantified gap that leaves the market focused on execution rather than on the joint venture alone.

Stock remains below yearly high

Leidos Holdings stock was last at USD 119.45 on October 5, 2026, with a session low of USD 116.59, a session high of USD 120.20 and volume of 1,480,000 shares. The 52-week range was USD 98.86 to USD 205.77, placing the stock 41.95 percent below its yearly high.

Leidos Holdings stock key data

  • Company: Leidos Holdings, Inc.
  • ISIN: US5253271028
  • Ticker: LDOS
  • Trading venue: NYSE
  • Price (as of October 5, 2026, 4:01 p.m. ET): USD 119.45
  • Market capitalization: USD 15.0 billion (as of October 5, 2026)
  • 52-week range: USD 98.86-205.77 (as of October 5, 2026)
  • Sector / Industry: Technology / Information Technology Services

Upcoming dates for Leidos Holdings stock

  • November 3, 2026: Third quarter 2026 results and conference call

Leidos scheduled its third quarter 2026 results for November 3, 2026, according to Leidos on October 6, 2026. The report will show whether defense momentum and the portfolio reshaping can offset pressure in Health.

More news and analysis on Leidos Holdings stock

Disclaimer...

en | US5253271028 | LEIDOS HOLDINGS | boerse | 70248469 | bgmi